Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-036362

Chief Commercial Officer sold 16,074 shares at $7.50 ($120,528)

From the SEC's structured data for this filing

Trades in this filing

VAN BEEK JEROEN B · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-16 Sale : show line 1 in the form −16,074 $7.50 $120,528 333,726 D
Open-market sales · 16,074 sh · avg $7.50 · $120,528
Loading xslF345X03/doc4.xml…